ERBB2 and cancer: The luminal cancers are almost all ER+ subtype; the HER2+subtype cancers are ER–/PR–, but have amplification and over-expression of the HER2 gene; BPBC cancers overlap mostly with triple negative (ER–/PR–/HER2–, or TNBC) cancers [35].